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Background & Aim: The amount of coronary calciﬁcation mea-
sured by coronary computed tomography (CCT) correlates with
increased risk of coronary events. We aimed to measure the effect
of coronary risk factors on the degree of coronary calciﬁcation in
clinically indicated CCT studies in the Saudi population.
Methods: Clinically indicated patients were scanned using 64
slice CCT to measure Agatston coronary calciﬁcation score.
Results: 1287 patients were scanned with mean age of
52 ± 13.2 years, 65% males, & 35% females. Chest pain was the
indication in 80% of cases. There was 37% diabetic, 58% hyperten-
sive, 23.6% hyperlipidemic, 13% smoker, and 32%with family his-
tory of coronary daises. The mean calcium score was high in males
compared to females, 99.6 ± 341, and 54.2 ± 182, P< 0.001, in
patients P40 years compared to <40 years, 92.5 ± 314, and
6.1 ± 39.4, P< 0.0001, in diabetic pat, compared to non-diabetic,
125.9 ± 387, and 52.7 ± 212, P< 0.0001, in hypertensive pat
compared to non-hypertensive, 114.8 ± 360, and 25 ± 107,
P< 0.0001, in hyperlipidemic pat compared to non-hyperlipi-
demic, 177.5 ± 407, and 44 ± 222, P< 0.0001, in n patients with
body mass index P25 compared to those <25, 72 ± 295, and
45 ± 141, P< 0.05 and in patients with HbA1c P8 compared to
<8, 152 ± 467, and 76.4 ± 365, P< 0.01.
Conclusion: Coronary calciﬁcation is signiﬁcantly higher in
patients with classical coronary risk factors. Poorly controlled
diabetes is associated with higher risk of coronary calciﬁcation.
doi:10.1016/j.jsha.2011.02.061
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Background: Femoral arterial sheath thrombosis and distal
embolization is a well-recognized complication of cardiac catheter-
ization and may result in serious comorbidities like acute leg ische-
mia. Heparinized saline ﬂushes are used during diagnostic
coronary angiography to prevent thrombus formation within the
lumen of the sheath. However, the use of prophylactic intravenous
heparin following the femoral arterial sheath insertion is contro-
versial. The aim of this study was to evaluate the effectiveness of
2000 units’ heparin intravenous bolus versus saline placebo on
thrombus formation within arterial sheath during the diagnostic
coronary angiography.
Methods: Eligible patients were randomized to receive either
study drug or placebo at the time of femoral sheath insertion.
Arterial access was obtained via femoral arterial approach using
access 6F–7F sheaths and catheters. The sheath was aspirated
and ﬂushed for presence of thrombus after each catheter exchange
and at the end of the procedure. Five milliliters of blood was ex-
tracted and visualized on clean gauze and if thrombus was noticed
further aspiration was performed followed by saline ﬂush. The
primary end point was the effectiveness of study drug on reducing
the incidence of sheath-thrombus formation.
Results: 304 patients were randomized into two arms: 147 pa-
tients received intravenous heparin and 157 patient received pla-
cebo. The baseline characteristics were similar. Sheath thrombi
were observed in 20% of the total cohort.
Of the heparin arm, 12% (19 patients) developed sheath
thrombus formation versus 26% (42 patients) in placebo arm, p
value = 0.002. Adjusted logistic regression showed that the only
predictor for the sheath thrombi formation was the study drug.
The odds ratio of developing a thrombus when a study drug is
not used was 2.5 (95% CI: 1.4–4.5, p= 0.003). There were no ad-
verse events noticed.
Conclusion: IV heparin signiﬁcantly reduced thrombus forma-
tion with no adverse events. Therefore, our data suggest using
IV heparin routinely.
doi:10.1016/j.jsha.2011.02.062
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Background: Contrast induced nephropathy CIN is an acute
deterioration of renal function deﬁned as increase in serum creat-
inine by 25% above the baseline value within 48 h after adminis-
tration of contrast agent, several risk factors may aggravate CIN
and DM is a strong predisposing factor.
Objectives: To study the effect of contrast administration on re-
nal function and the relation of diabetes mellitus and other risk
factors which can predispose patients to CIN.
Methods: Open label, single center study in cath lab a total of
1117 patients underwent cardiac catherization between January
and December 2009, all patients in that period included in this
study, Acute coronary syndrome and stable CAD patients.
Results: Total of 1117 patients, 55 (4%) patients developed
CIN, 35 (64%) patients are diabetics, 39 (71%) patients are hyper-
tensive, 38 (56%) patients under went diagnostic cardiac cath and
17 (34%) had PCI, 23 (41%) patients had body weight <70 kg
and 44 (80%) patients received omnipauqe contrast media.
Conclusion: This study conclude that hypertension and DM are
the major risk factors in our patients, diabetic patients in particu-
lar should be closely monitored for CIN and preventive measures
should be strictly enforced.
doi:10.1016/j.jsha.2011.02.063
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Introduction and aim of the study: Coronary Artery Disease
(CAD) in Saudis is reaching epidemic levels, Type II Diabetes
(DM) is the highest in the region. The pattern, and extent of Cor-
onary Athero-Thrombosis (CAT) is not studied. We aim to
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investigate the spectrum of CAT of Saudi patients (pts) with Acute
Coronary Syndromes (ACS).
Methods: We reviewed 60 pts Intra-Vascular Ultrasound
(IVUS) studies, including 105 IVUS runs of whom 38 runs were
carried out for Borderline Lesions Pre-Runs (PR). Thirty-ﬁce pts
ﬁles were reviewed for Risk Factors, diagnosis and Troponin I
(CT-I) levels.
Results: Twenty eight Males (80%), 7 Females (20%), average
age 64 years. Twenty seven DM (77.14%), 8 NDM (22.86%) and
14 smokers (40%). Twelve (34.29%) recent ST segment Elevation
Myocardial Infarction (STEMI), 8 (22.86%) Non-STEMI (NSTE-
MI), and 5 (42.85%) Unstable Angina (UA). CT-I positive in 19
(54.29%) of whom 8 (42.11%) STEMI, 7 (36.84%) NSTEMI
and 4 (21.05%) UA. DM with NSTEMI revealed a signiﬁcantly
larger Plaque Area (p= 0.0003*) and Plaque Burden (p=
0.0033*) when Compared with NDM. While Average Luminal
Diameters, Vessel Diameters, Vessel, and Plaque Areas were sig-
niﬁcantly larger (p value: 0.0497*, 0.0080*, 0.0088*, 0.0200*) more
in NDM with recent STEMI. The percent Volume obstruction
however were not signiﬁcantly different between the two groups.
Conclusion: This preliminary data is the ﬁrst of a kind IVUS
analysis study ever generated in Saudis. We aim to establish the
ﬁrst database of Coronay Atherothrombotic Deseases and the ﬁrst
core-lab in the Middle East.
doi:10.1016/j.jsha.2011.02.064
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Introduction and aim of the study: Coronary Artery Disease
(CAD) in Saudi population is reaching epidemic levels, coupled
with sedentary life style the rate of Type II Diabetes Mellitus
(DM) is among the highest in the region. The pattern, extent
and distribution of Coronary Athero-Thrombosis (CAT) in Saudi
population is yet to be studied.
Our study is designed to investigate the spectrum of CAT of our
patients presenting with Acute Coronary Syndromes (ACS).
Methods: As part of our database Registry of patients who
underwent IntraVascular Ultrasound (IVUS) at Prince Salman
Heart Center/King Fahad Medical City. A total of 60 patients
studies were retrospectively reviewed, a total of 105 IVUS runs
were studied, of whom 38 runs (35 patients) were carried out for
evaluating Borderline Lesions Pre-Runs (PR) and 67 runs (25 pa-
tients) were carried out for post stent deployment optimisation
(PS).
We report our ﬁrst 35 consecutive patients who underwent cor-
onary angiography and had IVUS for evaluating their borderline
lesions. Patients ﬁles were reviewed for their Risk Factors, present-
ing Diagnosis and Troponin I (CT-I) levels.
Thirty eight IVUS runs were analysed in cooperation with Dr.
Lisette Okkels Jensen IVUS Core Lab, Odense University Hospi-
tal, Odense – Denmark. INDEC Medical system software, Inc.,
2210 Martin Ave. Santa Clara, CA 95050 was used.
Each run was divided into 1mm slices, each of which required 2
separate Luminal and External Elastic Membrane (EEM) tracings,
lesions within 5 mm Proximal and Distal to the maximal Plaque
Burden(PB) were analysed1. The following selected parameters
were obtained:
Deﬁnitions: Average Luminal Diameter (ALD), the average of
Minimal Luminal Diameter and Maximal Luminal Diameter.
Luminal Area (LA), the External Elastic Membrane (EEM)
Cross Sectional Area (CSA) of the vessel lumen.
Average Vessel Diameter (AVD), the average of all vessel EEM
diameters obtained from each slice.
Vessel Area (VA), the CSA of the vessel wall using EEM of
each slice.
Plaque Area (PA), the EEM CSA – Lumen CSA.
Plaque Burden (PB), the Plaque CSA/EEM CSA.
Remodelling Index (RMI), the EEM CSA Lesion/EEM CSA
of the average Proximal and Distal Reference Vessel (RV), ob-
tained from the most normal looking segments with the least PB
5 mm Proximal and Distal to the Lesion1.
EEM Volume, the sum (
P
) EEM CSA
Lumen Volume, the sum (
P
) Lumen CSA
Plaque Volume, the sum (
P
)) (EEM CSA – Lumen CSA)
Percent Plaque Volume, the (
P
) (EEM CSA – Lumen CSA /
EEM CSA) · 100
Results: Twenty eight patients were Males (80%) and 7 Fe-
males (20%), average age 54 years. Twenty seven patients were
diabetics (DM) (77.14%) and eight were non-diabetics (NDM)
(22.86%), 14 patients were smokers & ex-smokers (40%). Patients
were admitted for acute coronary syndromes including, 12 patients
(34.29%) with recent or late presentation ST segment Elevation
Myocardial Infarction (STEMI) two of them underwent Primary
PCI, 8 patients (22.86%) with non-STEMI (NSTEMI), and 5 pa-
tients (42.85%) with Unstable Angina (UA).
Nine patients had no f/u Cardiac Troponin-I (CT-I) of whom
four had baseline CT-I levels. Five patients had no baseline CT-I
levels (30 pts were analysed). CT-I was positive in 19 (54.29%) of
whom 8 patients with STEMI (42.11%), 7 patients with NSTEMI
(36.84%) and 4 patients with UA (21.05%). Total with UA/
NSTEMI 11 patients (57.88%).
We found that the most signiﬁcant differences were observed
in Diabetics presenting with NSTEMI revealing a signiﬁcantly
larger Plaque Area and Plaque Burden (P value: 0.0003*.
0.0033*) compared with Non-Diabetics. While Average Luminal
Diameters, Vessel Diameters, Vessel, and Plaque Areas were sig-
niﬁcantly larger (P value: 0.0497*, 0.0080*, 0.0088*, 0.0200*) and
particularly obvious in Non-Diabetics presenting with recent
STEMI. The percent Volume obstruction however were not sig-
niﬁcantly different.
Discussion: Although the data is considered preliminary yet this
is the ﬁrst of a kind Pilot data ever generated in Saudi population.
We look forward to establish the ﬁrst database of Coronay Ather-
othrombotic Deseases and establish the ﬁrst core-lab in the Middle
East.
doi:10.1016/j.jsha.2011.02.065
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Background: The drug-eluting stents (DES) are used in the
majority of patients who undergo percutaneous coronary interven-
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